Access to anti-retroviral drugs, male in Angola
Angola: Access to anti-retroviral drugs, male was 52.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Angola, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Angola is 52.0%, measured in 2024. That is the highest value across all 25 years on record.
That represents a change of up 8.3% on the previous year and up 136.4% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Angola peaked at 52.0% in 2024 and was at its lowest, 0.0%, in 2000.
Angola ranks 113th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Angola, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 3.0% | — |
| 2007 | 5.0% | +66.7% |
| 2008 | 8.0% | +60.0% |
| 2009 | 10.0% | +25.0% |
| 2010 | 13.0% | +30.0% |
| 2011 | 15.0% | +15.4% |
| 2012 | 16.0% | +6.7% |
| 2013 | 19.0% | +18.8% |
| 2014 | 22.0% | +15.8% |
| 2015 | 26.0% | +18.2% |
| 2016 | 28.0% | +7.7% |
| 2017 | 32.0% | +14.3% |
| 2018 | 34.0% | +6.2% |
| 2019 | 31.0% | -8.8% |
| 2020 | 34.0% | +9.7% |
| 2021 | 39.0% | +14.7% |
| 2022 | 43.0% | +10.3% |
| 2023 | 48.0% | +11.6% |
| 2024 | 52.0% | +8.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.6% | 0.0% | 10.0% | 10 |
| 2010s | 23.6% | 13.0% | 34.0% | 10 |
| 2020s | 43.2% | 34.0% | 52.0% | 5 |
Countries ranked near Angola
More gender data for Angola
- Child population (UN estimates and projections) 19,236 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 2.13 % change on previous year (2030)
- Population 25,925 (2030)
- Working-age population (UN estimates and projections) 25,925 (2030)
- Population (UN estimates and projections), annual growth rate 3.47 % change on previous year (2030)
- Age population, age 00, female, interpolated 676,513 (2025)
- Age population, age 00, male, interpolated 689,235 (2025)
- Age population, age 01, female, interpolated 656,125 (2025)
- Age population, age 01, male, interpolated 667,064 (2025)
- Age population, age 02, female, interpolated 640,250 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Angola?
- Access to anti-retroviral drugs, male in Angola was 52.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Angola?
- The highest recorded value was 52.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Angola?
- The lowest recorded value was 0.0% in 2000.
- How does Angola rank for access to anti-retroviral drugs, male?
- Angola ranks 113th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Angola?
- Over the last ten years it is up 136.4%. The long-run trend across the full record is volatile.
- Where does this Angola data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.